Identification and detection of new biomarkers that identify the beginning stages of diseases is critical for achieving successful medical treatment. EDP Biotech Corporation is a medical device company that is developing a sophisticated technological platform for detecting early stage colon cancer from minimal patient blood samples, enabling early diagnosis, in a timely and cost effective manner. This technology is poised to transform colon cancer patient screening to a simple blood test that saves both time and money, as well as vastly improves patient compliance and prognosis, since current methodologies are more invasive and have a significantly lower detection rate.
Categories: cancer, COMPANIES, Diagnostics, Technology Report
Leave a Reply